Ceftazidime是一种新型头孢菌素,我院1984年开始应用,并获得较满意的疗效,本文共收集34例感染性疾病患者51例次使用本药治疗现总结如下。临床资料:男性32例,女性2例,年龄30～90岁,平均68.5岁。病种包括呼吸系统感染42例次(肺部感染35例次,肺炎6例次,肺炎并败血症1例次),胆道感染4例次,腹腔感染3例次,泌尿系感染2例次。全部采用静脉给药,每日2～6克, Ceftazidime is a new cephalosporin, our hospital started to apply in 1984, and obtained more satisfactory curative effect, this article collected a total of 34 cases of infectious diseases in 51 patients using the drug treatment are summarized as follows. Clinical data: 32 males and 2 females, aged 30 to 90 years, mean 68.5 years old. The disease included 42 respiratory infections (35 pulmonary infections, 6 pneumonia and 1 pneumonia with sepsis), 4 biliary tract infections, 3 abdominal infections and 2 urinary infections. All intravenous administration, 2 to 6 grams daily,